- Home
- TVGN vs INMB Comparison
TVGN vs INMB Comparison
Compare TVGN & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVGN
- INMB
- Stock Information
- Founded
- TVGN 2020
- INMB 2015
- Country
- TVGN United States
- INMB United States
- Employees
- TVGN N/A
- INMB N/A
- Industry
- TVGN Blank Checks
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- TVGN Finance
- INMB Health Care
- Exchange
- TVGN Nasdaq
- INMB Nasdaq
- Market Cap
- TVGN 193.1M
- INMB 176.5M
- IPO Year
- TVGN N/A
- INMB 2019
- Fundamental
- Price
- TVGN $1.20
- INMB $6.38
- Analyst Decision
- TVGN Strong Buy
- INMB Strong Buy
- Analyst Count
- TVGN 1
- INMB 3
- Target Price
- TVGN $10.00
- INMB $24.33
- AVG Volume (30 Days)
- TVGN 817.5K
- INMB 660.2K
- Earning Date
- TVGN 08-13-2025
- INMB 07-31-2025
- Dividend Yield
- TVGN N/A
- INMB N/A
- EPS Growth
- TVGN N/A
- INMB N/A
- EPS
- TVGN N/A
- INMB N/A
- Revenue
- TVGN N/A
- INMB $50,000.00
- Revenue This Year
- TVGN N/A
- INMB $82.14
- Revenue Next Year
- TVGN N/A
- INMB $28,750.98
- P/E Ratio
- TVGN N/A
- INMB N/A
- Revenue Growth
- TVGN N/A
- INMB N/A
- 52 Week Low
- TVGN $0.26
- INMB $4.32
- 52 Week High
- TVGN $3.09
- INMB $10.50
- Technical
- Relative Strength Index (RSI)
- TVGN 48.04
- INMB 37.45
- Support Level
- TVGN $1.09
- INMB $6.68
- Resistance Level
- TVGN $1.31
- INMB $8.05
- Average True Range (ATR)
- TVGN 0.10
- INMB 0.62
- MACD
- TVGN -0.02
- INMB -0.10
- Stochastic Oscillator
- TVGN 26.19
- INMB 10.31
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.